Altern Ther Health Med. 2024 Aug;30(8):16-21.
This study investigated the role of titanium clip marking during endoscopy in managing patients with upper gastrointestinal bleeding (UGIB) for whom endoscopic hemostasis has proven ineffective.
A total of 63 UGIB patients admitted to the Affiliated Hospital of Zunyi Medical University between January 2018 and November 2020 were selected as the study cohort. Patients were randomly assigned to one of two groups: the control group (n=23) and the combined group (n=40). The control group underwent transcatheter arterial embolization (TAE), while the combined group received endoscopic metallic titanium clip-assisted TAE. This study compared the rates of successful embolization, clinical success, recurrence, operation time, radiation exposure time, radiation dosage, levels of hs-CRP, Cor, NE, TNF-α, IL-6, and ADH before and after treatment, as well as postoperative complications between the two groups.
The combined group of patients exhibited significantly higher rates of successful embolization and clinical success compared to the control group (P < .05). Additionally, the recurrence rate and levels of hs-CRP, Cor, NE, TNF-α, IL-6, and ADH were significantly lower in the combined group compared to the control group (P < .05). Furthermore, patients in the combined group had shorter operation times, reduced radiation exposure times, and lower radiation dosages compared to the control group (P < .05). There was no statistically significant difference in the occurrence of postoperative complications between the two groups (P > .05).
Using titanium clip marking during endoscopy provides valuable guidance in managing patients with upper gastrointestinal bleeding who have not responded to endoscopic hemostasis. This finding is especially relevant in digital subtraction angiography (DSA) and transcatheter arterial embolization (TAE) treatments. It enhances the clinical efficacy and safety of the procedure.
本研究旨在探讨内镜钛夹标记在治疗内镜止血无效的上消化道出血(UGIB)患者中的作用。
选取遵义医科大学附属医院 2018 年 1 月至 2020 年 11 月收治的 63 例 UGIB 患者作为研究对象。将患者随机分为两组:对照组(n=23)和联合组(n=40)。对照组行经导管动脉栓塞术(TAE),联合组行内镜金属钛夹辅助 TAE。比较两组患者的栓塞成功率、临床成功率、复发率、手术时间、辐射暴露时间、辐射剂量、治疗前后 hs-CRP、Cor、NE、TNF-α、IL-6、ADH 水平以及术后并发症。
联合组患者的栓塞成功率和临床成功率明显高于对照组(P<0.05)。联合组的复发率及 hs-CRP、Cor、NE、TNF-α、IL-6、ADH 水平明显低于对照组(P<0.05)。联合组患者的手术时间更短,辐射暴露时间和辐射剂量均低于对照组(P<0.05)。两组患者术后并发症发生率差异无统计学意义(P>0.05)。
内镜下钛夹标记为内镜止血无效的上消化道出血患者的治疗提供了有价值的指导,尤其在数字减影血管造影(DSA)和经导管动脉栓塞术(TAE)治疗中具有重要意义。它提高了该治疗方法的临床疗效和安全性。